Warning: This security is no longer trading.
Company filed for Chapter 11 bankruptcy and will sell itself to Danish drugmaker Zealand Pharma
Valeritas Holdings, Inc. (VLRX): Price and Financial Metrics
VLRX Price/Volume Stats
| Current price | $0.26 | 52-week high | $11.39 |
| Prev. close | $0.28 | 52-week low | $0.25 |
| Day low | $0.25 | Volume | 1,651,900 |
| Day high | $0.32 | Avg. volume | 694,630 |
| 50-day MA | $0.81 | Dividend yield | N/A |
| 200-day MA | $2.05 | Market Cap | 2.17M |
VLRX Stock Price Chart Interactive Chart >
Valeritas Holdings, Inc. (VLRX) Company Bio
Valeritas Holdings, a commercial-stage medical technology company, focuses on developing technologies to treat patients with Type 2 diabetes. It offers V-Go, a disposable insulin delivery device for basal-bolus therapy. The company was founded in 2006 and is based in Bridgewater, New Jersey.
VLRX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -84.15% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -91.18% |
Continue Researching VLRX
Here are a few links from around the web to help you further your research on Valeritas Holdings Inc's stock as an investment opportunity:Valeritas Holdings Inc (VLRX) Stock Price | Nasdaq
Valeritas Holdings Inc (VLRX) Stock Quote, History and News - Yahoo Finance
Valeritas Holdings Inc (VLRX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...